Mirum Pharmaceuticals, Inc. Purchase Agreements
3 Contracts & Agreements
- Asset Purchase Agreement, dated July 16, 2023, by and between Mirum Pharmaceuticals, Inc. and Travere Therapeutics, Inc (Filed With SEC on July 17, 2023)
- Asset Purchase Agreement, dated November 16, 2021, by and between the Registrant and Janssen Biotech, Inc (Filed With SEC on November 19, 2021)
- Amendment No. 1 to Revenue Interest Purchase Agreement, dated September 28, 2021 (Filed With SEC on September 29, 2021)
